An experimental vaccine developed by researchers at the University of Pennsylvania’s schools of Medicine and Veterinary Medicine shows an increase in survival time for dogs with spontaneous non-Hodgkin’s lymphoma.
The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine.
Read more at Science Daily: Efficacy of Non-Hodgkin’s Lymphoma Vaccine Demonstrated in Dogs
Filed under: Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma vaccine
